Last update 01 Nov 2024

TGF-β3 x CALCR x ERα

Basic Info

Related Targets
TGF-β3CALCRERα

Related

1
Drugs associated with TGF-β3 x CALCR x ERα
CDRI-99-373
Target
CALCR x ERα x TGF-β3
Mechanism
CALCR modulators [+2]
Active Org.
Central Drug Research InstituteCentral Drug Research Institute
Originator Org.
Central Drug Research InstituteCentral Drug Research Institute
Active Indication
Osteoporosis
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with TGF-β3 x CALCR x ERα
Login to view more data
100 Translational Medicine associated with TGF-β3 x CALCR x ERα
Login to view more data
0 Patents (Medical) associated with TGF-β3 x CALCR x ERα
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free